Table 1 Baseline characteristics of the active and controlled groups
From: Effects and mechanism of moderate aerobic exercise on impaired fasting glucose improvement
Variables | Active (n = 60) | Controlled (n = 60) |
|---|---|---|
Age (years) | 42.4 ± 5.8 | 44.1 ± 6.6 |
Male, n (%) | 33 (55.0) | 35 (58.3) |
BMI (kg/m2) | 24.6 ± 3.3 | 24.8 ± 3.7 |
Overweight, n (%) | 10 (16.7) | 12 (20.0) |
Obese, n (%) | 9 (15.0) | 8 (13.3) |
Waist circumference (cm) | 84.4 ± 7.6 | 82.9 ± 8.3 |
Smoking, n (%) | 23 (38.3) | 21 (35.0) |
Hypertension, n (%) | 16 (26.7) | 18 (30.0) |
Dyslipidemia, n (%) | 19 (31.7) | 18 (30.0) |
SBP (mmHg) | 127.8 ± 16.4 | 125.9 ± 15.7 |
DBP (mmHg) | 79.8 ± 10.6 | 78.5 ± 11.7 |
HR (bpm) | 73.7 ± 10.4 | 76.5 ± 9.9 |
TG (mmol/L) | 1.8 ± 0.4 | 1.9 ± 0.3 |
TC (mmol/L) | 5.7 ± 0.6 | 5.8 ± 0.5 |
LDL-C (mmol/L) | 3.6 ± 0.3 | 3.7 ± 0.4 |
HDL-C (mmol/L) | 1.1 ± 0.3 | 1.1 ± 0.2 |
Lp(a) (mg/L) | 132.4 ± 15.6 | 135.7 ± 17.3 |
FBG (mmol/L) | 6.3 ± 0.5 | 6.4 ± 0.4 |
HbA1c (%) | 5.6 ± 0.4 | 5.6 ± 0.5 |
Cr (μmol/L) | 98.7 ± 10.6 | 99.2 ± 9.9 |
BUN (mmol/L) | 5.6 ± 1.3 | 5.9 ± 1.4 |
Hs-CRP (mg/L) | 5.2 ± 1.1 | 5.6 ± 1.0 |
ROCK2 activity (mg/mL) | 58.7 ± 6.0 | 60.2 ± 7.3 |
Fasting C-peptide level (nmol/L) | 0.26 ± 0.05 | 0.28 ± 0.07 |
Fasting insulin level (pmol/L) | 13.6 ± 2.2 | 14.1 ± 2.8 |
Daily average exercise time (min) | 5.2 ± 3.8 | 5.9 ± 3.5 |
Aspirin, n (%) | 28 (46.7) | 26 (43.3) |
ACEI, n (%) | 9 (15.0) | 7 (11.7) |
ARB, n (%) | 4 (6.7) | 5 (8.3) |
CCB, n (%) | 4 (6.7) | 3 (5.0) |
Statins, n (%) | 14 (23.3) | 13 (21.7) |